Kevin Lee - 14 Oct 2021 Form 4 Insider Report for BICYCLE THERAPEUTICS plc (BCYC)

Role
Chief Executive Officer, Director
Signature
/s/ Lee Kalowski, Attorney-in-Fact
Issuer symbol
BCYC
Transactions as of
14 Oct 2021
Net transactions value
-$300,016
Form type
4
Filing time
18 Oct 2021, 18:22:39 UTC
Previous filing
13 Oct 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCYC Ordinary Shares Sale $277,860 -4,631 -2% $60.00 225,454 14 Oct 2021 Direct F1, F2
transaction BCYC Ordinary Shares Sale $19,216 -320 -0.14% $60.05 225,134 15 Oct 2021 Direct F1, F3
transaction BCYC Ordinary Shares Sale $2,940 -49 -0.02% $60.00 225,085 18 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.06 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.10 inclusive.